NP
NeuroPace, Inc.
NPCE · NASDAQ
$14.28 +1.03% (+$0.14)
1M +1.85%
Market Cap $482.4M
P/E Ratio -
Div. Yield -
ROE 119.68%
Bulios Fair Price
$8.53
40.3% downside
Trenutna cena
$14.28
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NPCE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
18 /100
Expensive P/B 40.60x
P/S 4.88x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 18.21%
Rev. growth 29.99%
FCF growth N/A
Profitability
20 /100
Weak Net margin 19.34%
Op. margin 15.26%
FCF margin 11.75%
Quality
13 /100
Poor ROE 119.68%
ROA 19.71%
Asset turnover 1.02x
Debt
23 /100
High Current ratio 4.94x
Int. coverage -2.14x
Debt/Equity 5.88x
Stability
56 /100
Moderate Rev. volatility 11.69%
EPS volatility 3.43%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NPCE
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joel D. Becker
Employees
220
Headquarters
Mountain View
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report